These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15646654)

  • 41. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
    Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
    Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
    Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Sequential development of mantle cell lymphoma following chronic lymphocytic leukemia].
    Saga T; Ishihara T; Ito M; Kano S; Kanagawa M
    Rinsho Ketsueki; 2020; 61(3):251-256. PubMed ID: 32224586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.
    Foran JM; Cunningham D; Coiffier B; Solal-Celigny P; Reyes F; Ghielmini M; Johnson PW; Gisselbrecht C; Bradburn M; Matthews J; Lister TA
    Ann Oncol; 2000; 11 Suppl 1():117-21. PubMed ID: 10707792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prominent intrasinusoidal infiltration of the bone marrow by mantle cell lymphoma.
    Schenka AA; Gascoyne RD; Duchayne E; Delsol G; Brousset P
    Hum Pathol; 2003 Aug; 34(8):789-91. PubMed ID: 14506640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary cutaneous blastoid mantle cell lymphoma-case report.
    Estrozi B; Sanches JA; Varela PC; Bacchi CE
    Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinicopathologic features of mantle cell lymphoma and the significance of cyclin D1 in diagnosis].
    He X; Li G; Liu W; Lin Y; Li F; Liao D
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):300-4. PubMed ID: 12417084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma.
    Miao Y; Lin P; Wang W; Jeffrey Medeiros L; Lu X
    Am J Clin Pathol; 2016 Dec; 146(6):747-752. PubMed ID: 28028120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab-induced acute thrombocytopenia: a report of two cases.
    Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
    Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunophenotypic variations in mantle cell lymphoma.
    Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
    Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
    Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
    Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?
    Ortega V; Mendiola C; Rodriguez J; Ehman W; Qian YW; Velagaleti G
    Mol Cytogenet; 2021 Feb; 14(1):8. PubMed ID: 33541390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytogenetic findings in blastoid mantle cell lymphoma.
    Khoury JD; Sen F; Abruzzo LV; Hayes K; Glassman A; Medeiros LJ
    Hum Pathol; 2003 Oct; 34(10):1022-9. PubMed ID: 14608536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blastoid variant of mantle cell lymphoma in palatine tonsil.
    Valente VB; de Castro TF; Takamiya AS; Callestini R; Xavier-Junior JCC; Cortopassi GM; Neto SC; Collado FU; Biasoli ÉR; Miyahara GI; Bernabé DG
    Oral Oncol; 2021 Nov; 122():105552. PubMed ID: 34610523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Composite lymphoma cosisting of mantle cell lymphoma and follicular lymphoma].
    Matsuoka A; Tsushima T; Tanibuchi M; Katsuki N; Kushida Y; Takata K; Taoka T
    Rinsho Ketsueki; 2013 Nov; 54(11):2056-61. PubMed ID: 24305539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinicopathologic features and prognosis of mantle cell lymphoma: an analysis of 349 cases].
    Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):417-422. PubMed ID: 29886584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.